Arcturus Therapeutics Stock Performance
as on September 28, 2026 at 2:15 pm IST
Day's Low
Day's High
$13.30$14.48
3.97%
Downside
4.55%
Upside
52 Week's Low
52 Week's High
$5.50$24.1760.29%
Downside
74.51%
Upside
Arcturus Therapeutics share price movements today
- Previous Close
- $14.12
- Open
- $14.34
- Volume
- 621.7K
- Market Cap
- $393.7M
- Day's Low - High
- $13.30 - $14.48
- 52 Week Low - High
- $5.50 - $24.17
Arcturus Therapeutics Historical Returns
- 1 Month Return
- -8.82 %
- 3 Month Return
- + 101.31 %
- 1 Year Return
- -37.53 %
- 3 Year Return
- -45.56 %
- 5 Year Return
- -71.09 %
Arcturus Therapeutics Stock Fundamentals & Key Indicators
Check Arcturus Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$393.7M
EPS (TTM)
-3.33
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.16
Industry PE ratio
-8.76
PEG Ratio
0.10970865920021519
EBITDA
-82.9M
Revenue (TTM)
23.8M
Profit Margin
83.19%
Return On Equity TTM
-46.54%
Arcturus Therapeutics Stock Valuation
Track how Arcturus Therapeutics P/E has moved over time to understand its valuation trends.
Arcturus Therapeutics in the last 5 years
Lowest (-28.24x)
December 31, 2023
Industry (-8.76x)
December 31, 2025
Today (-2.55x)
December 31, 2025
Highest (47.97x)
December 31, 2022
Today’s Price to Earnings Ratio: -2.55x
Arcturus Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Arcturus Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $393.7M | -71.09% | -4.16 | 83.19% | 0.00% | |
| StrongBuy | $43.9B | 615.18% | -23.13 | 0.00% | 0.00% | |
| Neutral | $79.4B | -48.24% | -24.92 | -12.57% | 0.00% | |
| StrongBuy | $133.4B | 189.75% | 30.38 | 86.04% | 0.00% | |
| Buy | $81.1B | 30.25% | 18.82 | 84.86% | 0.47% |
Stock Returns calculator for Arcturus Therapeutics Stock including INR - Dollar returns
The Arcturus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Arcturus Therapeutics investment value today
Current value as on today
₹67,596
Returns
Returns from Arcturus Therapeutics Stock
Dollar Impact
₹5,124 (+5.12%)
Analyst Recommendation on Arcturus Therapeutics Stock
Based on 7 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 7 analysts, 71.42857142857143% of analysts recommend a 'BUY' rating for Arcturus Therapeutics. Average target price of $23.2
Arcturus Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Arcturus Therapeutics.
What analysts predicted
40.3%UPSIDE
Target Price
$23.2
Current Price
$13.85
Analyzed by
7 Analysts
High
$41
Target
$23.20
Low
$9
Arcturus Therapeutics target price $23.2, a slight upside of 40.3% compared to current price of $13.85. According to 7 analysts rating.
Indian Investors' Interest in Arcturus Therapeutics Stock
Search interest for Arcturus Therapeutics Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Arcturus Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Arcturus Therapeutics Annual Profit & Loss
All numbers in Millions USD
Arcturus Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Arcturus Therapeutics Annual Cash Flow
All numbers in Millions USD
Arcturus Therapeutics News & Key Events
Today's Timeline - 23 September
Thu, 01:35 AM
-Arcturus announces encouraging interim Phase 2 results for ARCT-810 and introduces next-gen mRNA delivery platform LUNAR 2.0.
Thu, 01:58 AM
-Arcturus showcases Phase 2 ARCT-810 data and updates on mRNA delivery platform, highlighting clinical progress and controlled disclosure strategy.
Thu, 02:00 AM
-Arcturus enters agreement to acquire myNEO, enhancing AI infrastructure for mRNA design and target identification.
Insights on Arcturus Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, ARCT stock has moved up by 101.3%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 610.0K → 2.95M (in $), with an average increase of 79.4% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -29.07M → -23.78M (in $), with an average increase of 10.6% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 98.3% return, outperforming this stock by 143.9%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 749.6%
About Arcturus Therapeutics
| Organisation | Arcturus Therapeutics |
| Headquarters | 10628 Science Center Drive, San Diego, CA, 92121, US |
| Industry | Biotechnology |
| CEO | Joseph E. Payne |
| E-voting on shares | Click here to vote |
Key Management of Arcturus Therapeutics
Name | Title |
|---|---|
Dr. Ye Zhang | Chief Regulatory & Quality Assurance Officer |
Mr. Joseph E. Payne M.Sc. | Founder, President, CEO & Director |
Mr. Joseph Roberts | Principal Accounting Officer & Controller |
Mr. Dennis M. Mulroy | Chief Financial Officer |
Ms. Natasha O. Bowman | Chief Human Resources Officer |
Dr. Igor Smolenov M.D., Ph.D. | Chief Development Officer |
Dr. Padmanabh Chivukula Ph.D. | Founder, Chief Scientific Officer, COO & Secretary |
Mr. Lance Kurata | Chief Legal Officer |
Ms. Neda Safarzadeh | Vice President and Head of IR/PR & Marketing |
Mr. Kevin T. Skol | Chief Business Officer |
FAQs
What is Arcturus Therapeutics share price today?
Arcturus Therapeutics share price today is $13.85 as on at the close of the market. Arcturus Therapeutics share today touched a day high of $14.48 and a low of $13.30.
What is the 52 week high and 52 week low for Arcturus Therapeutics share?
Arcturus Therapeutics share touched a 52 week high of $24.17 on and a 52 week low of $5.50 on . Arcturus Therapeutics stock price today i.e. is closed at $13.85,which is 42.70% down from its 52 week high and 151.82% up from its 52 week low.
What is Arcturus Therapeutics's market capitalisation today?
Arcturus Therapeutics market capitalisation is $0.00T as on .
How to invest in Arcturus Therapeutics Stock (ARCT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Arcturus Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcturus Therapeutics Shares that will get you 0.1083 shares as per Arcturus Therapeutics share price of $13.85 per share as on September 28, 2026 at 8:45 am IST.
What is the minimum amount required to buy Arcturus Therapeutics Stock (ARCT) from India?
Indian investors can start investing in Arcturus Therapeutics (ARCT) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Arcturus Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Arcturus Therapeutics share’s latest price of $13.85 as on September 28, 2026 at 8:45 am IST, you will get 0.7220 shares of Arcturus Therapeutics. Learn more about
fractional shares .
What are the returns that Arcturus Therapeutics has given to Indian investors in the last 5 years?
Arcturus Therapeutics stock has given -71.09% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?